ARCHIVES

ODAC Recommends TICE BCG Approval For Recurrent Bladder Cancer Prevention

This article is from The Cancer Letter archive.

Vol. 23 No. 01 | January 10, 1997

Download PDF Visit The Full Archive

Related Articles

FASEB Calls For 15% Increase For NIH Next Fiscal Year.

January 26, 2001

VEGF Levels Can Predict Tumor’s Resistance to Avastin

July 29, 2011

CCOP Budget Needs Hefty Increase To Fund 55 Awards At Requested Levels, Yates Says

January 30, 1987

Upton Closer To Decision On Control, Centers Merger; ACCC Defeats Motion In Opposition

March 16, 1979

Possible Breach of Patient Confidentially By Calif. Physician; NCI

May 6, 1994

NCI Seeks Health Care Provider Groups To Form Cancer Control Research Network

September 12, 1997